# Bogota Financial Corp.: financial statements, quarterly

BSBK · Nasdaq · CIK 1787414 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bsbk.md) · [Financials](/companies/bsbk/financials.md) · [Filings](/companies/bsbk/filings.md) · [Insiders](/companies/bsbk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bsbk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [6,072](/filings/0001437749-23-031606.md) | [6,628 d](/filings/0001437749-24-009812.md) | [7,410](/filings/0001437749-24-016999.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [(125)](/filings/0001437749-24-035128.md) | [(548) d](/filings/0001437749-25-009807.md) | [(287)](/filings/0001437749-25-016407.md) | [(281)](/filings/0001437749-25-026394.md) | [(253)](/filings/0001437749-25-034382.md) | [450 d](/filings/0001437749-26-010056.md) | [(28.0)](/filings/0001437749-26-016650.md) | [(52.6)](/filings/0001437749-26-027724.md) | [72.8](/filings/0001437749-25-034382.md) | [(10.5) d](/filings/0001437749-26-010056.md) | [212](/filings/0001437749-26-016650.md) | [98.7](/filings/0001437749-26-027724.md) |
| Net income | $k | [(29.1)](/filings/0001437749-24-035128.md) | [(1,178) d](/filings/0001437749-25-009807.md) | [(441)](/filings/0001437749-25-034382.md) | [(432)](/filings/0001437749-25-034382.md) | [(367)](/filings/0001437749-25-034382.md) | [(930) d](/filings/0001437749-26-010056.md) | [731](/filings/0001437749-26-027724.md) | [224](/filings/0001437749-26-027724.md) | [455](/filings/0001437749-25-034382.md) | [681 d](/filings/0001437749-26-010056.md) | [706](/filings/0001437749-26-027724.md) | [748](/filings/0001437749-26-027724.md) |
| Diluted EPS | $ per share | [0.00](/filings/0001437749-24-035128.md) | not reported | [(0.03)](/filings/0001437749-25-016407.md) | [(0.03)](/filings/0001437749-25-026394.md) | [(0.03)](/filings/0001437749-25-034382.md) | not reported | [0.06](/filings/0001437749-26-016650.md) | [0.02](/filings/0001437749-26-027724.md) | [0.04](/filings/0001437749-25-034382.md) | not reported | [0.06](/filings/0001437749-26-016650.md) | [0.06](/filings/0001437749-26-027724.md) |
| Basic EPS | $ per share | [0.00](/filings/0001437749-24-035128.md) | not reported | [(0.03)](/filings/0001437749-25-016407.md) | [(0.03)](/filings/0001437749-25-026394.md) | [(0.03)](/filings/0001437749-25-034382.md) | not reported | [0.06](/filings/0001437749-26-016650.md) | [0.02](/filings/0001437749-26-027724.md) | [0.04](/filings/0001437749-25-034382.md) | not reported | [0.06](/filings/0001437749-26-016650.md) | [0.06](/filings/0001437749-26-027724.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [25.0](/filings/0001437749-23-031606.md) | [24.9](/filings/0001437749-25-009807.md) | [14.4](/filings/0001437749-24-016999.md) | [17.6](/filings/0001437749-24-026803.md) | [21.0](/filings/0001437749-24-035128.md) | [52.2](/filings/0001437749-26-010056.md) | [25.6](/filings/0001437749-25-016407.md) | [20.3](/filings/0001437749-25-026394.md) | [31.2](/filings/0001437749-25-034382.md) | [35.6](/filings/0001437749-26-027724.md) | [27.9](/filings/0001437749-26-016650.md) | [29.9](/filings/0001437749-26-027724.md) |
| Total assets | $m | [927](/filings/0001437749-23-031606.md) | [939](/filings/0001437749-25-009807.md) | [961](/filings/0001437749-24-016999.md) | [975](/filings/0001437749-24-026803.md) | [979](/filings/0001437749-24-035128.md) | [971](/filings/0001437749-26-010056.md) | [930](/filings/0001437749-25-016407.md) | [922](/filings/0001437749-25-026394.md) | [926](/filings/0001437749-25-034382.md) | [905](/filings/0001437749-26-027724.md) | [877](/filings/0001437749-26-016650.md) | [875](/filings/0001437749-26-027724.md) |
| Total liabilities | $m | [789](/filings/0001437749-23-031606.md) | [802](/filings/0001437749-25-009807.md) | [824](/filings/0001437749-24-016999.md) | [838](/filings/0001437749-24-026803.md) | [842](/filings/0001437749-24-035128.md) | [834](/filings/0001437749-26-010056.md) | [792](/filings/0001437749-25-016407.md) | [783](/filings/0001437749-25-026394.md) | [785](/filings/0001437749-25-034382.md) | [764](/filings/0001437749-26-027724.md) | [735](/filings/0001437749-26-016650.md) | [733](/filings/0001437749-26-027724.md) |
| Shareholders' equity | $m | [138](/filings/0001437749-24-035128.md) | [137](/filings/0001437749-26-010056.md) | [136](/filings/0001437749-25-034382.md) | [136](/filings/0001437749-25-034382.md) | [137](/filings/0001437749-25-034382.md) | [137](/filings/0001437749-26-027724.md) | [138](/filings/0001437749-26-027724.md) | [138](/filings/0001437749-26-027724.md) | [141](/filings/0001437749-25-034382.md) | [141](/filings/0001437749-26-027724.md) | [142](/filings/0001437749-26-027724.md) | [142](/filings/0001437749-26-027724.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [68.0 d](/filings/0001437749-24-035128.md) | [(224) d](/filings/0001437749-25-009807.md) | [(2,881)](/filings/0001437749-25-016407.md) | [1,651 d](/filings/0001437749-25-026394.md) | [(288) d](/filings/0001437749-25-034382.md) | [(1,042) d](/filings/0001437749-26-010056.md) | [(16.0)](/filings/0001437749-26-016650.md) | [1,920 d](/filings/0001437749-26-027724.md) | [292 d](/filings/0001437749-25-034382.md) | [1,007 d](/filings/0001437749-26-010056.md) | [703](/filings/0001437749-26-016650.md) | [2,357 d](/filings/0001437749-26-027724.md) |
| Capital expenditure | $k | [102 d](/filings/0001437749-24-035128.md) | [53.4 d](/filings/0001437749-25-009807.md) | [266](/filings/0001437749-25-016407.md) | [234 d](/filings/0001437749-25-026394.md) | [43.1 d](/filings/0001437749-25-034382.md) | [51.8 d](/filings/0001437749-26-010056.md) | [36.2](/filings/0001437749-26-016650.md) | [0.0 d](/filings/0001437749-26-027724.md) | [15.4 d](/filings/0001437749-25-034382.md) | [18.8 d](/filings/0001437749-26-010056.md) | [29.3](/filings/0001437749-26-016650.md) | [211 d](/filings/0001437749-26-027724.md) |
| Share repurchases | $k | [822 d](/filings/0001437749-24-035128.md) | [745 d](/filings/0001437749-25-009807.md) | [270](/filings/0001437749-25-016407.md) | [735 d](/filings/0001437749-25-026394.md) | [415 d](/filings/0001437749-25-034382.md) | [276 d](/filings/0001437749-26-010056.md) | [398](/filings/0001437749-26-016650.md) | [0.0 d](/filings/0001437749-26-027724.md) | [(356) d](/filings/0001437749-25-034382.md) | [1,084 d](/filings/0001437749-26-010056.md) | [125](/filings/0001437749-26-016650.md) | [1,210 d](/filings/0001437749-26-027724.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [13.5](/filings/0001437749-23-031606.md) | [13.1](/filings/0001437749-24-016999.md) | [13.1](/filings/0001437749-24-026803.md) | [13.0](/filings/0001437749-24-035128.md) | [12.9](/filings/0001437749-25-016407.md) | [12.8](/filings/0001437749-25-026394.md) | [12.7](/filings/0001437749-25-034382.md) | [12.7](/filings/0001437749-26-016650.md) | [12.6](/filings/0001437749-26-027724.md) | [12.7](/filings/0001437749-25-034382.md) | [12.6](/filings/0001437749-26-016650.md) | [12.5](/filings/0001437749-26-027724.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 12,761,313 at 2026-08-13, from the cover of the [10-Q filed 2026-08-13](/filings/0001437749-26-027724.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.